Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
374
Recruiting Now
374
Top Conditions in Phase 1 / Phase 2
NCT07072494 Phase 1, Phase 2
Recruiting
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patien...
Condition
Acute Lymphoblastic Leukemia
Enrollment
30 pts
Location
China
Sponsor
Zhujiang Hospital
NCT06836505 Phase 1, Phase 2
Recruiting
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma ...
Condition
Neuroblastoma (NB)
Enrollment
10 pts
Location
China
Sponsor
Sun Yat-Sen University Cancer
NCT04807257 Phase 1, Phase 2
Recruiting
Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment
Condition
Malignant Fungating Wound
Enrollment
18 pts
Location
Taiwan
Sponsor
NanoRay Biotech Co., Ltd.
NCT06545175 Phase 1, Phase 2
Recruiting
Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surge...
Condition
Hearing Loss
Enrollment
11 pts
Location
Germany
Sponsor
Hannover Medical School
NCT06795412 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid T...
Condition
Advanced Solid Tumours
Enrollment
220 pts
Location
United States, Spain
Sponsor
Pyxis Oncology, Inc
NCT06235229 Phase 1, Phase 2
Recruiting
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
Condition
Multiple Myeloma
Enrollment
110 pts
Location
China
Sponsor
Gracell Biotechnologies (Shang
NCT06187402 Phase 1, Phase 2
Recruiting
A Study of LM-24C5 For Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
49 pts
Location
United States
Sponsor
LaNova Medicines Limited
NCT03311503 Phase 1, Phase 2
Recruiting
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted ...
Condition
Severe Combined Immunodeficiency, X Linked
Enrollment
12 pts
Location
United States
Sponsor
David Williams
NCT04711824 Phase 1, Phase 2
Recruiting
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Phys...
Condition
Breast Cancer
Enrollment
41 pts
Location
United States
Sponsor
Colette Shen
NCT05146440 Phase 1, Phase 2
Recruiting
Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination...
Condition
Advanced Soft-tissue Sarcoma
Enrollment
195 pts
Location
Spain
Sponsor
Grupo Espanol de Investigacion
NCT04998396 Phase 1, Phase 2
Recruiting
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Cli...
Condition
Canavan Disease
Enrollment
26 pts
Location
United States
Sponsor
Aspa Therapeutics
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or...
Condition
Non-Small Cell Lung Cancer
Enrollment
251 pts
Location
United States, France, Germany
Sponsor
Pierre Fabre Medicament
NCT03223610 Phase 1, Phase 2
Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapse...
Condition
Lymphoma
Enrollment
155 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06292780 Phase 1, Phase 2
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or R...
Condition
Relapsed/Refractory Systemic Light Chain Amyloidosis
Enrollment
220 pts
Location
United States, South Korea, Spain
Sponsor
Regeneron Pharmaceuticals
NCT05310591 Phase 1, Phase 2
Recruiting
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
26 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux
NCT07145450 Phase 1, Phase 2
Recruiting
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Ant...
Condition
PDAC
Enrollment
96 pts
Location
Denmark, Germany, Netherlands
Sponsor
Anocca AB
NCT06524960 Phase 1, Phase 2
Recruiting
Denosumab for Type 1 Diabetes
Condition
Type 1 Diabetes
Enrollment
45 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06996782 Phase 1, Phase 2
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Condition
Advanced or Metastatic Non-small Cell Lung Cancer
Enrollment
152 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca
NCT06120582 Phase 1, Phase 2
Recruiting
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With H...
Condition
Hemophilia B
Enrollment
28 pts
Location
Belarus, Russia
Sponsor
Biocad
NCT06831123 Phase 1, Phase 2
Recruiting
Pathways 2 Success
Condition
Conduct Disorder
Enrollment
120 pts
Location
United States
Sponsor
University of Minnesota
NCT07011186 Phase 1, Phase 2
Recruiting
A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Trea...
Condition
Myeloid Malignancy
Enrollment
138 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiatio...
Condition
Acute Myeloid Leukemia
Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT05804669 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's...
Condition
Cushing Syndrome
Enrollment
18 pts
Location
United States
Sponsor
Crinetics Pharmaceuticals Inc.
NCT05256641 Phase 1, Phase 2
Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lympho...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT06721013 Phase 1, Phase 2
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Condition
Immune Thrombocytopenia (ITP)
Enrollment
58 pts
Location
United States, China, Denmark
Sponsor
Eli Lilly and Company